Financing ·
Gossamer Bio completed an early settlement of its exchange offer, cancelling $181,052,000 in aggregate principal of…
GOSSGossamer Bio, Inc.
Gossamer Bio completed an early settlement of its exchange offer, cancelling $181,052,000 in aggregate principal of 5.00% Convertible Senior Notes due 2027. In exchange, the company issued $65,174,000 of new 7.50% Convertible Senior Secured First Lien Notes due 2030, 254,150,441 shares of common stock, 33,402,727 prefunded warrants, and 135,789,000 purchase warrants. Approximately $18,948,000 of the original convertible notes remain outstanding.